← All organizations

Evotec

For profitWebsite ↗

Also known as: Evotec AG | Evotec Neurosciences GmbH | Just-Evotec Biologics

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

May 16, 2025

Timeline

1990s

Jun 1, 1993
Evotec— Founded

2010s

Jul 14, 2010
DeveloGen AG, Germany— Acquired
Apr 19, 2011
Kinaxo— Acquired
Jun 1, 2011
Compound Focus— Acquired
Jan 3, 2013
Cell Culture Service GmbH— Acquired
Mar 24, 2014
Bionamics GmbH— Acquired
May 28, 2014
Euprotec— Acquired
Oct 26, 2016
Cyprotex— Acquired
Jul 30, 2017
Aptuit Inc.— Acquired
May 22, 2019
Just Biotherapeutics— Acquired

Drugs by trial phase (22 distinct, 19 trials)

Phase 3 (0 own, 10 via acquisition)

Phase 2 (4 own, 3 via acquisition)

Phase 1 (1 own, 4 via acquisition)

Indications

Studied for

Subsidiaries (9 direct, 9 total across the full acquisition tree)

Recent trials (7)

NCT06943378Lead sponsorPhase 1May 16, 2025
NCT01128452Study directorPhase 2Jun 1, 2010
NCT00738595Lead sponsorPhase 2Aug 1, 2008
NCT00622752Lead sponsorPhase 2Feb 1, 2008
NCT00526968Lead sponsorPhase 1Sep 1, 2007
NCT00401284Lead sponsorPhase 2Nov 1, 2006
NCT00380003Lead sponsorPhase 2Sep 1, 2006

Details

Founded: Hamburg, DE Jun 1, 1993
Last known activity: May 16, 2025

Notes

CRO